<DOC>
	<DOCNO>NCT01061554</DOCNO>
	<brief_summary>The purpose study compare short term absorption EPA DHA triglyceride ( TG ) release normal soft gel capsule new patent pending vehicle provide gastric stable emulsion .</brief_summary>
	<brief_title>Bioavailability Study Long Chain Omega-3 Fatty Acids From Gastric Stable Emulsion</brief_title>
	<detailed_description>The present study comprise design well effect pre-emulsification ω-3 fatty acid bioavailability docosahexaenoic acid eicosapentaenoic acid . In-vitro study show long-term steric stabilization o/w-emulsion obtain arrest oil droplet gelatin continuous gel matrix . The emulsion also stable upon dissolution gel matrix physiological condition in-vitro hence refer gastric stable emulsion ( GSE ) . In bioavailability study , healthy young student recruit presented two different single-dose treatment fish oil contain 5 gram ω-3 fatty acid ; one group receive fatty acid traditional soft gel capsule , whereas group receive fatty acid use GSE technology . Time resolve ( 2 - 26 hour ) blood plasma analysis intake single dose ω-3 fatty acid reveal significantly increase AUC0-26h Cmax EPA EPA + DHA administer GSE compare traditional soft gel capsule .</detailed_description>
	<criteria>Student NordTrondelag University College Healthy ( know condition ) Males female age 19 29 year Fish allergy Ongoing consumption omega3 fatty acid Subjects receive anticoagulation nonsteroid antiinflammatory treatment Subjects know metabolic syndrome ; diabetes , hypercholesterol , hypertension , obesity</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>29 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Bioavailability</keyword>
	<keyword>Eicosapentaenoic acid</keyword>
	<keyword>Docosahexaenoic acid</keyword>
	<keyword>Soft gel capsule</keyword>
	<keyword>Gastric stable emulsion</keyword>
	<keyword>Omega-3</keyword>
	<keyword>Tri-glycerides</keyword>
	<keyword>Marine phospholipid</keyword>
</DOC>